Treatments for Rare ovarian cancer
FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.
ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing dataFDA-approved treatments (6)
- Doxildoxorubicin HCL liposome injectionJohnson & Johnson Pharmaceutical Research & Dev.
- Oncoscint CR/OVSatumomab pendetideCytogen Corporation
- Elaheremirvetuximab soravtansine-gynxImmunoGen, Inc.Approved Nov 2022
- Rubracarucaparibpharma&Approved Apr 2018
- LynparzaolaparibAstraZeneca Pharmaceuticals LPApproved Aug 2017
- ZejulaniraparibGlaxoSmithKline, LLC.Approved Mar 2017
Patient support programs (4)
Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.
ZEJULA
GSK
Ovarian Cancer
Verified 6d ago
copay card
Copay CardPatient Assistance
Accepting applications
Oncoscint CR/OV
Cytogen Corporation
Oncoscint CR/OV — Contact Cytogen Corporation
Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications
Lynparza
AstraZeneca
Ovarian Cancer
Link unavailable
copay card
Copay CardPatient Assistance
Accepting applications
1-800-236-9933Call for current details
Rubraca
pharma&
Rubraca — Contact pharma&
Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications